Valerie Chen, MD
Ophthalmology · Fort Mill, SCNPI 1750624987
Payments from drug & device makers
Across 63 payments — averaging $20.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tarsus Pharmaceuticals, Inc.$227
- Eyevance Pharmaceuticals LLC$217
- Harrow Eye, LLC$189
- Oyster Point Pharma, Inc.$183
- Novartis$173
- Alcon$132
- plus $185 from 6 others
What the payments were for
- Food & beverage$1,305100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. | 6 | $227 |
| Eyevance Pharmaceuticals LLC | 19 | $217 |
| Harrow Eye, LLC | 7 | $189 |
| Oyster Point Pharma, Inc. | 8 | $183 |
| Novartis | 8 | $173 |
| Alcon | 6 | $132 |
| Sun Pharmaceutical Industries Inc. | 3 | $68 |
| Bausch & Lomb Americas Inc. | 2 | $47 |
| AbbVie | 1 | $20 |
| Omeros Corporation | 1 | $20 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $18 |
| Lumenis, Inc | 1 | $12 |
How this compares
$1,305 in reported general payments places this provider in the 40th percentile of 293 ophthalmology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErythromycinErythromycin Base | 72 | $678 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 54 | $542 |
| Doxycycline Monohydrate | 14 | $170 |
| Tramadol Hcl | 49 | $42 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Fort Mill
- John WellsWest Columbia$7.1M
- William ClarkWest Columbia$6.2M
- Daniel AlfaroCharleston$4.6M
- Kerry SolomonMt Pleasant$4.6M
- Eric JablonCharleston$1.2M
- George WaringMt Pleasant$1M
- John KerrisonCharleston$975K
- Karolinne RochaCharleston$799K
- John PayneWest Columbia$574K
- Mona CamacciCharleston$534K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.